PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAE4. A total of 15 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $3,839,000 | -21.8% | 2,700,000 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $4,907,000 | +17.9% | 2,700,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $4,161,000 | +0.3% | 2,700,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $4,148,000 | -53.4% | 2,700,000 | -56.5% | 0.00% | -55.6% |
| Q3 2013 | $8,909,000 | +5.7% | 6,200,000 | 0.0% | 0.01% | -10.0% |
| Q2 2013 | $8,428,000 | – | 6,200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 25,974,000 | $40,197,000 | 19.49% |
| WOLVERINE ASSET MANAGEMENT LLC | 17,710,000 | $27,332,000 | 0.58% |
| UBS AG | 2,700,000 | $4,161,000 | 0.00% |
| DEUTSCHE BANK AG\ | 475,000 | $731,000 | 0.00% |
| Jefferies Group LLC | 52,000 | $80,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,400,000 | $2,158,000 | 0.00% |